2023年9月20日 · Atgam is a polyclonal antibody, or an immune globulin, given as an intravenous (IV, into a vein) infusion. Atgam is used to fight a type of white blood cell called a T-lymphocyte (also called a thymocyte or T-cell).

Aplastic anemia (moderate to severe) in patients unsuitable for bone marrow transplantation.

Anti-thymocyte globulin (ATG) is an infusion of horse or rabbit-derived antibodies against human T cells and their precursors (thymocytes), which is used in the prevention and treatment of acute rejection in organ transplantation and therapy of aplastic anemia due to …

ATGAM Sterile Solution contains lymphocyte immune globulin, anti-thymocyte globulin [equine]. It is the purified, concentrated, and sterile gamma globulin, primarily monomeric IgG, from hyperimmune serum of horses immunized with human thymus lymphocytes. ATGAM is a transparent to slightly opalescent aqueous protein solution.

ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine] sterile solution) This product information is intended only for residents of the United States. for Consumers: ATGAM - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources; for Healthcare professionals:

2024年12月30日 · What is Atgam (equine)? Lymphocyte immune globulin anti-thymocyte (also called equine anti-thymocyte immune globulin), is an immunosuppressant that lowers your body's immune system. The immune system helps your body fight infections.

ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine]) dosing and administration guidelines for aplastic anemia & renal allograft rejection. This site is intended for U.S. healthcare professionals.

2023年12月9日 · Easy-to-read patient leaflet for Atgam. Includes indications, proper use, special instructions, precautions, and possible side effects.

Administer ATGAM intravenously and use with concomitant immunosuppressants. The recommended dose is 10 to 15 mg/kg daily intravenously for 14 days. Additional alternate-day therapy up to a total of 21 doses may be given. The recommended dose is 10 to 20 mg/kg daily intravenously for 8 to 14 days.

ATG (ATGAM®) may be used for either moderate or severe aplastic anemia (SAA). Goals of therapy: Cyclosporine + ATG is given to increase white blood cells, red blood cells, and platelets.